Open Access

An imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in rats

  • Natalia R Salvetti1, 2,
  • Carolina G Panzani1, 2,
  • Eduardo J Gimeno3,
  • Leandro G Neme2,
  • Natalia S Alfaro1 and
  • Hugo H Ortega1, 2Email author
Reproductive Biology and Endocrinology20097:68

https://doi.org/10.1186/1477-7827-7-68

Received: 02 May 2009

Accepted: 01 July 2009

Published: 01 July 2009

Abstract

Background

Cystic ovarian disease is an important cause of infertility that affects bovine, ovine, caprine and porcine species and even human beings. Alterations in the ovarian micro-environment of females with follicular cysts could alter the normal processes of proliferation and programmed cell death in ovarian cells. Thus, our objective was to evaluate apoptosis and proliferation in ovarian cystic follicles in rats in order to investigate the cause of cystic follicle formation and persistence.

Methods

We compared the number of in situ apoptotic cells by TUNEL assay, expression of active caspase-3 and members of Bcl-2 family by immunohistochemistry; and cell proliferation by the expression of the proliferation markers: PCNA and Ki-67.

Results

The proliferation index was low in granulosa of tertiary and cystic follicles of light exposed rats when compared with tertiary follicles of control animals, while in theca interna only cystic follicles presented low proliferation index when compared with tertiary follicles (p < 0.05). The granulosa of cysts exhibited a similar cell DNA fragmentation to early atretic follicles. In the granulosa and theca interna, active caspase-3 shown similar immunostaining levels in tertiary and cystic follicles (p < 0.05). The granulosa cells presented high expression of Bcl-2, Bcl-xL and Bcl-w in the tertiary and cystic follicles with diminishing intensity in the atretic follicles, except with Bcl-w where the intensity was maintained in the atretic follicles (p < 0.05). The expression of Bax was weak in the healthy and cystic follicles. In the theca interna, Bcl-2 expression was the same as the pattern found in the granulosa; no differences were found between tertiary and cystic follicles from both groups for Bcl-xL and Bcl-w. The expression of Bax in this layer was higher in the tertiary follicles of the treated animals (p < 0.05) while the values for cystic follicles were similar to those in the tertiary follicles of controls. The theca externa showed low expression of the pro and anti-apoptotic proteins.

Conclusion

These results show that the combination of weak proliferation indices and low apoptosis observed in follicular cysts, could explain the cause of the slow growth of cystic follicles and the maintenance of a static condition without degeneration, which leads to their persistence. These alterations may be due to structural and functional modifications that take place in these cells and could be related to hormonal changes in animals with this condition.

Background

Folliculogenesis, ovulation, and the subsequent formation of the corpus luteum are intricate processes that involve dramatic changes in ovarian cell function. Once initiated, follicular growth is a continuous process without resting phases, ending at ovulation [1]. One of the main modifications in granulosa cell function is the rapid switch from the highly proliferative stage characterizing granulosa cells of preovulatory follicles to the non-proliferative, terminally differentiated phase of luteal cells. Cell cycle regulation is a complex process involving a balance between several regulatory molecules, and can be altered by numerous external signals in multiple steps [1]. Proliferating cell nuclear antigen (PCNA), and Ki-67 are proliferation-associated proteins. PCNA is required for DNA synthesis and appears to be involved in follicular growth. Expression of PCNA in granulosa cells begins upon the formation of a primary follicle, and its level of expression appears to increase during the gonadotropin-dependent stages of preovulatory follicular development [2, 3]. Ki-67 is expressed in G1/S/G2/M but not G0 cells [2]. Both proteins can be detected by immunohistochemistry and they are excellent markers of cellular proliferation [1].

A fine balance between survival and apoptotic factors may determine whether a follicle will continue developing or undergo atresia [1, 46]. The progression of apoptosis in follicular cells is dependent on the cooperative regulation of different paracrine and autocrine factors; it is likely that none of these factors is specifically required in the control of follicle growth or death. Regulation of apoptotic signaling in the ovary is generally achieved by Fas system and the Bcl-2 family [5, 7, 8]. Members of the Bcl-2 family of proteins are considered among the main regulatory proteins acting at the mitochondrial level. They can be divided into those having either an antiapoptotic (e.g. Bcl-2, Bcl-W, Bcl-xL) or proapoptotic (Bax, Bad, Bim, Bcl-xS, Bod, Bok/Mtd) function. The antiapoptotic proteins can block the activation of effector caspases, caspase-3, caspase-6 and caspase-7, which in turn transduce the apoptotic signals [911]. Bcl-2 resides on the nuclear/endoplasmatic reticulum membrane, with a smaller portion on the mitochondrial membrane, and, it has been suggested that when it is present in the outer mitochondrial membrane it can block apoptosis by inhibiting the release of apoptosis-inducing factors, cytochrome c and the intermembrane protein DIABLO-Smac from the mitochondria [11, 12]. Bcl-xL and Bcl-w are usually abundant in the mitochondrial membrane where they inhibit the release of apoptotic inducing factors [13].

On the other hand, Bax plays a major role in initiating the release of cytochrome c. This protein may form a pore in the outer membrane of the mitochondria allowing cytochrome c to leak out. Therefore, the Bax: Bcl-2 (or Bcl-xL or Bcl-w) ratio might be important in the mitochondria-dependent apoptosis cascade for the release of cytochrome c and DIABLO-Smac [11, 12].

Cystic ovarian disease (COD) and/or polycystic ovarian syndrome (PCOS) are disorders of the reproduction that affect bovine, ovine, caprine and porcine species and even human beings [1418]. The heterogeneity of the syndrome is reflected in many animal models of polycystic ovaries (PCO) [17, 1922]. In the bovine livestock, COD is an important cause of infertility and it is characterized by anovulation, anoestrus, and the persistence of follicles with a larger diameter than the ovulatory follicle [14].

Several experimental models for PCO have been developed in rats [17, 1922]. Estradiol valerate (EV) has been employed to induce this syndrome and cause a sudden appearance of polycystic ovaries due to disturbances in metabolic and physiologic processes [19, 20]. A simple method to induce the disease is to expose mature rats to an environment with constant light during 90 days. After this time, the females develop persistent follicles that remain while the environmental conditions persist [17]. Constant illumination acts on the hypothalamus to induce a fail in the preovulatory LH surge and ovulation is thus prevented, leading to the follicular persistence [17]. Such method induce cysts gradually, similar to the PCOS and is also the least invasive of all the methods developed till now.

Although it is widely accepted that dysfunction of the hypothalamic-pituitary-gonadal axis is an important aetiological factor of cystic follicles, delay of follicle regression after ovulation failure is an alternative cause of cysts [23]. Alterations that occur in the ovarian micro-environment of females that present follicular cysts could alter the normal processes of proliferation and programmed cell death in ovarian cells. Based on this, our objective was to evaluate apoptosis and proliferation in ovarian follicles in anovulatory COD rats compared with rats with regular oestral cycles in order to investigate the mechanisms underlying follicular survival or atresia. We compared the number of apoptotic cells by Terminal Deoxynucleotidyl Transferase Biotin-dUTP Nick End Labelling assay (TUNEL), activated caspase-3 and Bcl-2 family members expression by immunohistochemistry and cell proliferation by expression of the proliferation markers: PCNA and Ki-67.

Methods

Animals and treatment

All procedures were carried out according to the Guide for the Care and Use of Laboratory Animals [24]. Female Wistar rats (16 weeks-old), were provided by the Centre for Experimental Biology and Laboratory Animal Sciences (Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral). Before the experiment, the animals were kept under a controlled cycle of light-darkness (lights on from 8:00 h to 20:00 h), at 18–22°C with free access to water and commercial food (Cargill, Argentina). Lighting was provided by banks of General Electric 4 coolwhite 40 W fluorescent tubes to obtain an intensity of 350 l× to 1 m from the floor.

Fifteen animals displaying at least two normal 5 day estrous cycles just prior to treatments were divided into two groups. A control group (n = 5) of females of the same age as the treated animals remained in the normal light-dark conditions; the continuous light group (n = 10) were placed in the conditions described except that the light cycle was extended to 24 h [17].

Smears obtained by vaginal washing were examined under a microscope for the relative abundance of nucleated epithelial cells, cornified cells and leukocytes [25]. Cycles with duration of 5 days were considered regular. The presence of cornified cells in the smears for a minimum of 10 consecutive days was defined as persistent vaginal cornification and considered as confirmation of follicular cystic development [17].

Tissue sampling

The animals in the light exposed group were sacrificed approximately 2 weeks after persistent vaginal cornification was established; those in the control group were sacrificed after 12 weeks in proestrus to obtain healthy growing follicles.

After being anaesthetized with a cocktail of ketamine/xylazine (40/4 mg/kg) via subcutaneous injection, the rats were killed by decapitation; trunk blood was collected; and serum was stored at -20°C until being used for hormone assays. The ovaries were dissected and fixed in 10% (v/v) buffered formalin for 6 h at 8°C and were washed in phosphate buffered saline (PBS). For light microscopy, fixed tissues were dehydrated in an ascending series of ethanol, cleared in xylene, and embedded in paraffin. Five micrometer-thick sections were mounted in slides previously treated with 3-aminopropyltriethoxysilane (Sigma-Aldrich, St. Louis, MO, USA) and were stained with haematoxylin-eosin for a previous observation.

Immunohistochemistry

The details, suppliers and concentrations of antibodies used are reported in Table 1. Each antibody was assayed in at least five sections of each ovary from each individual. A streptavidin-biotin immunoperoxidase method was performed as previously described [17, 26]. Briefly, after deparaffinization, microwave pre-treatment (antigen retrieval) was performed by incubating the sections in 0.01 M citrate buffer (pH 6.0). The endogen peroxidase activity was inhibited with 1% H2O2 and nonspecific binding was blocked with 10% (v/v) normal goat serum. All sections were incubated with the primary antibodies for 18 h at 4°C and then for 30 min at room temperature with biotinylated secondary antibodies (preabsorbed with rat serum to avoid unspecific binding) selected specifically for each of the two types of primary antibodies used (mono or polyclonal). Visualization of the antigens was achieved by the streptavidin-peroxidase method (BioGenex, San Ramon, CA) and 3.3-diaminobenzidine (Liquid DAB-Plus Substrate Kit – Zymed, San Francisco, CA) was used as the chromogen. Finally, the slides were washed in distilled water and counterstained with Mayer's haematoxylin, dehydrated and mounted. The different follicular categories studied were classified according to the Nomina Histologica [27]. We analysed tertiary healthy follicles and atretic follicles type I, II or III [4] in both groups. We also assessed cystic follicles in treated rats.
Table 1

Used antibodies, suppliers, antigen retrieval and dilutions.

Antibodies

Clone/Source

IHC antigen retrieval

Dilution

Primary antibodies

PCNA

PC-10. Novocastra (UK)

Buffer Citrate pH 6. Microwave.

1:100

Ki-67

MIB-5. Dako (Denmark)

Buffer Citrate pH 6. Microwave.

1:60

Active Caspase-3

Polyclonal. R&D systems (USA)

Without antigen retrieval

1:500

Bax

Polyclonal. PU347-UP-Biogenex (San Ramon, CA, USA)

Without antigen retrieval

1:30

Bcl-2

Clone 100. Zymed (San Francisco, CA, USA)

Without antigen retrieval

1:50

Bcl-w

Polyclonal. ab 13525-Abcam (Cambridge, UK)

Without antigen retrieval

1:100

Bcl-xL

Polyclonal. ab 45002-Abcam (Cambridge, UK)

Without antigen retrieval

1:500

Secondary antibodies

Anti-rabbit IgG

Goat Polyclonal. 65-6140-Zymed (San Francisco, CA, USA)

-

1:100

Anti-mouse IgG

Goat Polyclonal. AP181B Chemicon (Temecula, CA, USA)

-

1:100

To verify immunoreaction specificity, adjacent control sections were subjected to the same immunohistochemical method replacing primary antibodies with rabbit and mouse non-immune sera. The specificity of the secondary antibodies was tested by incubation with primary antibodies raised against human antigens with a proven negative reaction with the rat tissues: anti-CD45 (Clon: PD7/26 & 2B11; Dako, Carpinteria, CA) and anti-Ki-67 (polyclonal, rabbit anti-human Ki-67; Dako, Carpinteria, CA). To exclude the possibility of non-suppressed endogenous peroxidase activity some sections were incubated with DAB reagent alone.

Identification of apoptotic nuclei by TUNEL assay

Apoptotic nuclei were identified using the ApopTag® Plus Peroxidase In Situ Apoptosis Detection Kit (Chemicon) according to the manufacturer's protocol. Endogenous peroxidase was blocked by immersing slides in 3% hydrogen peroxide. Negative controls were treated in the same manner except that the TdT labelling enzyme was omitted [28]. Apoptotic nuclei were visualized with diaminobenzidine (DAB) as the chromogen substrate (Biogenex, San Ramon, CA), and counterstained with haematoxylin. Cells showing dark brown staining from the colorimetric reaction were considered positive for DNA fragmentation [29].

Image analysis

Image analysis was performed using an Image Pro-Plus 3.0.1 system (Media Cybernetics, Silver Spring, MA, USA). For the immunohistochemistry technique, images were digitized by a CCD colour video camera (Sony, Montvale, NJ, USA) mounted on a conventional light microscope (Olympus BH-2, Olympus Co., Japan), using an objective magnification of × 40. The microscope was prepared for Koehler illumination. This was achieved by recording a reference image of an empty field for the correction of unequal illumination (shading correction) and by calibrating the measurement system with a reference slide to determine background threshold values. The reference slides contained a series of tissue sections stained in the absence of a primary antibody. The positive controls were used as inter-assay controls to maximize the levels of accuracy and robustness of the method [18, 26, 30].

The methodological details of image analysis as a valid method for quantifying expression levels have been described previously [18, 26, 3133]. The major strength of the imaging approach used in this study is visualization of the in situ localization of proteins within cells of interest. In the past decade, computerized image analysis systems have been developed to obtain objective and accurate quantification of biological markers [26, 34].

The image analysis score was calculated separately in each follicular wall layer (granulosa theca interna and theca externa) from at least 50 images of the following structures: tertiary, atretic (type I, II or III), and cystic follicles from ovaries of both groups.

TUNEL, Ki-67 and PCNA staining were evaluated by counting positive cells/total cells for each layer to obtain an index of positive cells. For PCNA marker, only intense positive nucleuses were considered positive.

The immunohistochemical-stained area (IHCSA) for the determination of caspase-3, bax, Bcl-xL, Bcl-w and bcl-2 immunohistochemistry was used. The IHCSA was calculated as a percentage of the total area evaluated through the colour segmentation analysis, which extracts objects by locating all objects of the specific colour (brown stain). The brown stain was selected with a sensitivity of 4 (maximum 5) and a mask was then applied to separate the colours permanently. The images were then transformed to a bi-level scale TIFF format.

Statistics

The number of individuals per group was obtained from a sample size calculation that evaluated the number of individuals necessary to produce an estimate of the immunoreactivity that would fall within 0.4 units of the real value. The formula used was: n = Z2*SD2/d2, where n = sample size, Z = level of confidence (1.96 for 95%); SD = standard deviation (0.3); d = 0.4. As we were able to reject the null hypothesis in most cases, type 2 errors were not considered a problem.

A statistical software package (SPSS 11.0 for Windows, SPSS Inc., Chicago, IL, USA) was used to perform the statistical tests. The differences between the groups of data were assessed by one-way ANOVA, followed by Duncan's multiple range tests. P < 0.05 values was considered significant. Results were expressed as mean ± SEM.

Results

The successful induction of the disease was confirmed by observation of ovarian morphology. In treated animals were observed healthy developing follicles, follicles showing different degrees of atresia, many large cysts with thickened granulosa cell layer or with scant granulosa cells; and hypertrophic interstitial glands. Corpora lutea were absent in all cases. Ovaries from control animals exhibited follicles in various stages of development including primary, secondary and tertiary follicles, as well as atretic follicles, interstitial glands and corpora lutea.

Cell proliferation

The proliferation index was evaluated by PCNA and Ki-67. Only nuclear staining was found with both cellular proliferation markers while the quantity of PCNA-positive cells was higher than that of Ki-67, possibly due to their higher sensitivity. Both antibodies showed similar patterns in the different follicular categories. Granulosa cells of tertiary follicles from the control group (Figures 1G and 1J) showed a higher proliferation index in relation to tertiary and cystic follicles from the treated group [See Additional file 1]. In theca interna cystic follicles presented lower proliferation index when compared with tertiary follicles in both groups [See Additional file 2] (Figures 1I and 1L). Cystic and atretic follicles showed minor proliferation in theca interna layer (Figures 1H, I, K and 1L). The theca externa also had reduced proliferation index in atretic follicles of both groups and in cystic follicles [See Additional file 3] (Figures 1H, I, K and 1L).
Figure 1

Localization of caspase-3, Ki-67 and PCNA by immunohistochemistry and in situ apoptosis by TUNEL. Positive staining is shown as brown colouring of the cytoplasm/nucleus of the cells. Figures A, D, G and J correspond to healthy tertiary follicles; B, E, H and K correspond to atretic follicles and C, F, I and L correspond to cystic follicles. (A-C) caspase-3 immunolocalization, (D-F) TUNEL, (G-I) Ki-67 immunolocalization and (J-L) PCNA immunolocalization. G: Granulosa, TI: Theca Interna, TE: Theca Externa. Bars = 20 μm.

Cell death

TUNEL

The highest percentage of positive cells was found in granulosa cells of atretic follicles type II in both groups [See Additional file 1] (Figure 1E). Tertiary follicles in both groups presented few marked cells (Figure 1D). The cysts exhibited a similar staining to the type I and III atretic follicles (Figure 1F). The theca interna had a few positive cells in all follicular categories, except in tertiary follicles of the treated group, which presented higher staining in relation to tertiary follicles of control animals [See Additional file 2]. Cysts remained at similar levels without significant differences into regard to tertiary follicles in either group (Figure 1D and 1F). Atretic follicles type II of the COD rats presented high levels of DNA fragmentation (Figure 1E). No differences were found in the theca externa between either follicular categories or groups (see additional file 3 for Immunohistochemical analysis of various proliferation and apoptotic proteins and DNA fragmentation in theca externa cells of rats with COD and controls).

Active caspase-3

Immunostaining for active caspase-3 was observed in cellular nucleus and cytoplasm. In the granulosa, the most intense staining was in the type II atretic follicles of treated rats, and the least intense was in the tertiary follicles of both groups and cystic follicles (p < 0.05) [See Additional file 1] (Figures 1A–C). In the theca interna, higher expression was observed in the type I atretic follicles in both groups and type II of the light-exposed group [See Additional file 2]. Imunostaining in the theca externa was relatively low with no significant differences between follicular categories or groups [See Additional file 3].

Bcl-2 members

The granulosa cells presented high expression of antiapoptotic protein in the tertiary and cystic follicles (Figures 2D, F, G, I, J and 2L) with diminishing intensity in the atretic follicles of all categories [See Additional file 1] (Figures 2E and 2H), although intensity of Bcl-w was maintained in the atretic follicles of the control (Figure 2K) and light-exposed group, the highest expression was observed in the cystic and type III atretic follicles of the light-exposed group. In contrast, the expression of the pro-apoptotic protein Bax was weak in the healthy and cystic follicles (Figures 2A and 2C), higher in the type I and II atretic follicles (Figure 2B) and reduced in those of type III where the apoptotic granulosa cells had already been eliminated. In the theca interna Bcl-2 expression was the almost same as the pattern found in the granulosa [See Additional file 2] (Figures 2D to 2F); Bcl-xL expression did not differ between groups (Figures 2G to 2I); the atretic follicles type I of the light-exposed group showed the lowest levels of expression of Bcl-w and those type II showed higher levels of expression with regard to tertiary follilces of the two groups and cystic follicles.
Figure 2

Immunohistochemical localization of various Bcl-2 family proteins in healthy, atretic and cystic follicles of normal cycling and COD rats. Positive staining is shown as brown colouring of the cytoplasm of the cells. Figures A, D, G and J correspond to healthy tertiary follicles; B, E, H and K correspond to atretic follicles and C, F, I and L correspond to cystic follicles. (A-C) Bax immunolocalization, (D-F) Bcl-2 immunolocalization, (G-I) Bcl-xL immunolocalization and (J-L) Bcl-w immunolocalization. G: Granulosa, TI: Theca Interna, TE: Theca Externa. Bars = 20 μm.

On the other hand, the expression of Bax in this layer was higher in the tertiary follicles of the treated animals than those of cystic and type-I atretic follicles. The values for cystic follicles were similar to those in the tertiary follicles of controls (Figures 2A to 2C). The theca externa showed low expression of the pro and anti-apoptotic proteins with few differences between categories [See Additional file 3].

Discussion

In the present study we observed significant differences in the apoptosis and proliferation rate in follicles from rats with induced ovarian cysts. Cellular proliferation quantified by means of the immunodetection of PCNA and Ki-67 was higher in the granulosa cells of the healthy follicles in the control group than in the healthy and cystic follicles of light-exposed group. In theca cells, proliferation was lower in cysts than in tertiary follicles. Atretic follicles of all categories presented scarce proliferation indeces with Ki-67. The highest levels in proliferation found in atretic follicles with PCNA in both groups were at the beginning of the process of atresia (stadium I atretic follicles). This is probably because these follicles still express this protein (that has a prolonged half life) although some of their cells are already in elimination through the programmed cell death.

In bovine COD, Isobe and Yoshimura [23, 35] found a low index of proliferation in all follicular layers of cysts. They observed intense proliferation in the basal area of the granulosa of normal tertiary follicles, and a decrease in the atretic and cystic follicles. These results are consistent with those found in cystic follicles induced in bovines by ACTH [36] and in rats by oestradiol valerate [37]. However, our results on proliferation conflict with those of Das et al. [38] who found that proliferation indices in the cystic follicles of women with PCOD were high, which was attributed by the authors to the high levels of androgens that occur in the human disease. It should be taken into account that androgens are at normal levels in cows with COD [39] and that in the model used in this work, testosterone was even at levels below that found in rats in proestrus (unpublished data). It is known that the granulosa cells proliferate before the cyclic recruitment of the follicles under the influence of the gonadotropins, achieving high rates of mitosis in the total absence of these hormones. However, the final stage of development prior to ovulation is exclusively dependent on gonadotropins [40, 41]. There are reports that indicate that cellular proliferation in the granulosa is regulated by FSH, oestrogens and insulin as well as some growth factors [4143]. Androgens produced by the ovarian theca-interstitial cells play a decisive regulatory function in folliculogenesis because they serve as the precursors of estrogen synthesis in granulosa cells. In contrast, oestrogens enhance the responsiveness of ovarian follicles to gonadotropin stimulation and increase granulosa cell proliferation. However, excess androgen production impairs follicular function: it inhibits the effect of oestrogen on follicular growth, inhibits FSH induction of LH receptors in granulosa cells [44] and increases atresia among the follicles in rat ovaries [45, 46]. We have demonstrated that DNA fragmentation, as well as activated caspase-3, and Bax protein expression were significantly lower in all layers of tertiary and cystic follicles from COD rats than in normal atretic follicles from both groups, while the expression of survival proteins of the Bcl-2 family such as Bcl-2, Bcl-xL and Bcl-w was high in healthy and cystic follicles in both groups. Although, the cystic follicles showed moderate levels in the DNA fragmentation, these levels were not as high as those that showed the follicles with advanced degree of atresia. This is probably due to that certain percentage of cells of the cystic follicles degenerates by apoptosis without affects the structure of these follicles that stay through the time conserving the antrum, contrary to that observed in the process of follicular atresia, in which the follicles go reducing its size and the antrum disappears early. Anderson and Lee [47] found that during cystogenesis in a dehydroepiandrosterone (DHEA) induction model, apoptosis systematically progresses from the cumulus towards the mural granulosa layer and the outer layer of mural granulosa cells escapes apoptosis. In contrast, granulosa cells of atretic follicles undergo apoptosis in a random manner. The relating results to the high expression of Bcl-w in the cystic follicles could indicate the tendency of these to remain through the time. However there is maintenance in the expression of this protein in the healthy and atretic follicles what would be indicating Bcl-w doesn't have an important role in the survival of ovarian cells, contrarily to Bcl-2 and the Bcl-xL. On the other hand it is necessary to consider that exists a balance among pro and anti-apoptotic components that it can be altered and consequently an overexpression of pro-apoptotic elements (such as bax) it would originate a desbalance that would take to the cells in this condition toward the apoptosis. Isobe and Yoshimura [23, 35, 48] found low proliferation and apoptosis in cystic follicles in cows when compared with healthy follicles. These data are consistent with those of other authors who, using the TUNEL method and immunohistochemistry for the detection of caspase-3 and Bax in an experimental model of COD in bovines also found a lower index of proliferation and apoptosis in ovarian cysts than in healthy follicles [36]. In studies carried out in women with PCOD, Das et al [38] found high mRNA and protein expression of antiapoptotic factors such as cIAP-2 and Bcl-xL and lower expression of Bax and Caspase-3 in granulosa cells of cystic follicles, with similar values to those found in healthy follicles. On the other hand, Almahbobi et al. [49] found that granulosa cells from ovarian cysts of women with COD are normal, with low levels of apoptosis and high expression of gonadotropin receptors, specifically FSHr.

The response of the ovarian follicle to the combined effect of survival and death factors determines its ultimate fate: follicular atresia or ovulation. Progesterone is one of the factors that is induced by LH and that was reported to act as an antiapoptotic factor in luteinized rat and human granulosa cells [50]. Gonadotropins were also demonstrated to affect the apoptotic machinery by suppressing the expression of proapoptotic proteins [9, 51] as well as inducing the expression of antiapoptotic proteins [50]. However, Yacobi et al [50, 52] found that although gonadotropins (principally LH) decrease apoptosis in granulosa cells in cultured rat preovulatory follicles they increase apoptosis in theca/interstitial cells through the caspase-3 cascade. Tilly et al. [9] demonstrated that the inhibition of granulosa cell apoptosis and follicular atresia mediated by gonadotropin treatment may be linked to the ability of gonadotropins to reduce the amount of Bax present in granulosa cells, while maintaining a constitutive level of Bcl-2 and Bcl-xL expression. Moreover, the level of Bcl-xS mRNA is reduced by gonadotropin treatment and this effect may contribute to the shift in the balance of death inducer to death repressor gene expression. It is also possible that other hormonal signalling such as ovarian steroids or locally produced growth factors that can influence granulosa cell fate [9, 53, 54], serve as the primary regulators of Bcl-2 and Bcl-xL gene expression. It is interesting that Bax-deficient mice have abnormal follicles with an excessive number of granulosa cells [55]. Although there were no changes in the levels of serum gonadotropins in the treated animals [32], their constant levels (without the recurrent variations characteristic of the oestrus cycle) probably affect the expression of pro and anti-apoptotic proteins of the Bcl-2 family leading to follicular persistence over time.

We found moderate immunostaining of caspase-3 in the theca cell layer in all follicular categories in both groups. The role of caspase-3 in rat ovarian theca cells is not clear, since this cell type does not typically undergo apoptosis [4, 9, 56, 57]. It is possible that caspase-3 is activated in theca cells but does not lead to apoptosis because these cells lack the endogenous DNase I necessary to complete the apoptotic programme [56].

All the data presented here indicate that the cells of the follicular cysts are functional and, in fact, several authors have demonstrated this functionality, through cellular production of hormones, enzymes and their response to different stimuli [49, 58, 59].

Conclusion

Although much remains to be done in order to characterize the pathogenesis of cystic ovaries, we have confirmed that cellular proliferation and apoptosis are altered in cystic follicles of rats, as occurs in related diseases in different species. These results support the concept that the combination of weak proliferative activity and low levels of apoptosis observed in the follicular wall of cyst, could explain why the cystic follicles grow slowly and then maintain a static condition without degeneration, which leads to their persistence. These alterations may be due to structural and functional modifications that take place in these cells and could be related to the hormonal changes that happen in animals with this disease. Further studies will be needed to assess the specific role and regulation of each one of these cellular components and their participation in cystogenesis.

Declarations

Acknowledgements

This study was supported by grants from the National University of Litoral (Programs CAID). HHO and EJG are Research Career Members and NRS is a Fellow of the National Scientific Research Council (CONICET).

Authors’ Affiliations

(1)
Departamento de Ciencias Morfológicas, Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral
(2)
Centro de Experimentaciones Biológicas y Bioterio, Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral
(3)
Instituto de Patología, Facultad de Ciencias Veterinarias, Universidad Nacional de la Plata

References

  1. Robker RL, Richards JS: Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27KIP1. Mol Endocrinol. 1998, 12: 924-940. 10.1210/me.12.7.924.View ArticlePubMedGoogle Scholar
  2. Oktay K, Schenken RS, Nelson JF: Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat. Biol Reprod. 1995, 53: 295-301. 10.1095/biolreprod53.2.295.View ArticlePubMedGoogle Scholar
  3. El-Hefnawy T, Zeleznik AJ: Synergism between FSH and activin in the regulation of proliferating cell nuclear antigen (PCNA) and cyclin D2 expression in rat granulosa cells. Endocrinology. 2001, 142: 4357-4362. 10.1210/en.142.10.4357.View ArticlePubMedGoogle Scholar
  4. Hsueh AJ, Billig H, Tsafriri : An ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev. 1994, 15: 707-724.PubMedGoogle Scholar
  5. Hsu SY, Hsueh AJ: Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev. 2000, 80: 593-614.PubMedGoogle Scholar
  6. Amsterdam A, Sazón R, Keren-Tal I, Aharoni D, Dantes A, Rimon E, Land A, Cohen T, Dor Y, Hirsh L: Alternative pathways of ovarian apoptosis: death for life. Biochem Pharmacol. 2003, 66: 1355-1362. 10.1016/S0006-2952(03)00485-4.View ArticlePubMedGoogle Scholar
  7. Hussein MR: Apoptosis in the ovary: molecular mechanisms. Hum Reprod Update. 2005, 11: 162-177. 10.1093/humupd/dmi001.View ArticlePubMedGoogle Scholar
  8. Slot KA, Voorendt M, De Boer-Brouwer M, Van Vugt HH, Teerds KJ: Estrous cycle dependent changes in expression and distribution of Fas, Fas ligand, Bcl-2, Bax, and pro- and active caspase-3 in the rat ovary. J Endocrinol. 2006, 188: 179-192. 10.1677/joe.1.06165.View ArticlePubMedGoogle Scholar
  9. Tilly JL: Apoptosis and ovarian function. Rev Reprod. 1996, 1: 162-172. 10.1530/ror.0.0010162.View ArticlePubMedGoogle Scholar
  10. Tilly JL, Kowalski KI, Johnson AL, Hsueh AJW: Involvement of apoptosis in ovarian follicular atresia and posovulatory regression. Endocrinology. 1991, 129: 2799-2801.View ArticlePubMedGoogle Scholar
  11. Johnson AL, Bridgham JT: Caspase-mediated apoptosis in the vertebrate ovary. Reproduction. 2002, 124: 19-27. 10.1530/rep.0.1240019.View ArticlePubMedGoogle Scholar
  12. Gürsoy E, Ergin K, Başaloğlu H, Koca Y, Seyrek K: Expression and localisation of Bcl-2 and Bax proteins in developing rat ovary. Res Vet Sci. 2008, 84: 56-61. 10.1016/j.rvsc.2007.04.006.View ArticlePubMedGoogle Scholar
  13. Wilson-Annan J, O'Reilly LA, Crawford SA, Hausmann G, Beaumont JG, Parma LP, Chen L, Lackmann M, Lithgow T, Hinds MG, Day CL, Adams JM, Huang DC: Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol. 2003, 162: 877-887. 10.1083/jcb.200302144.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Garverick HA: Ovarian follicular cysts in dairy cows. J Dairy Sci. 1997, 80: 995-1004.View ArticlePubMedGoogle Scholar
  15. Jakimiuk AJ, Weitsman SR, Yen HW, Bogusiewicz M, Magoffin DA: Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002, 87: 5532-5538. 10.1210/jc.2002-020323.View ArticlePubMedGoogle Scholar
  16. Silvia WJ, Hatler TB, Nugent AM, Laranja Da Fonseca LF: Ovarian follicular cysts in dairy cows: an abnormality in folliculogenesis. Domest Anim Endocrinol. 2002, 23: 167-177. 10.1016/S0739-7240(02)00154-6.View ArticlePubMedGoogle Scholar
  17. Salvetti NR, Canal AM, Gimeno EJ, Ortega HH: Polycystic Ovarian Syndrome: temporal characterization of the induction and reversion process in an experimental model. Braz J Vet Res Anim Sci. 2004, 41: 389-395. 10.1590/S1413-95962004000600006.View ArticleGoogle Scholar
  18. Salvetti NR, Muller LA, Acosta JC, Gimeno JE, Ortega HH: Estrogen receptors α and β and progesterone receptors in ovarian follicles of cows with cystic ovarian disease. Vet Pathol. 2007, 44: 373-378. 10.1354/vp.44-3-373.View ArticlePubMedGoogle Scholar
  19. Mahesh VB, Mills TM, Bagnell CA, Conway BA: Animal models for study of polycystic ovaries and ovarian atresia. Adv Exp Med Biol. 1987, 219: 237-257.View ArticlePubMedGoogle Scholar
  20. Mahajan DK: Polycystic ovarian disease: animal models. Endocrinol Metab Clin North Am. 1988, 17: 705-732.PubMedGoogle Scholar
  21. Baravalle C, Salvetti NR, Mira GA, Pezzone N, Ortega HH: Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res. 2006, 37: 830-839. 10.1016/j.arcmed.2006.04.006.View ArticlePubMedGoogle Scholar
  22. Francou M, Durdos M, Salvetti NR, Baravalle C, Rey F, Ortega HH: Characterization of pituitary cell populations in rats with induced polycystic ovaries. Cells Tissues Organs. 2008, 188: 310-319. 10.1159/000123202.View ArticlePubMedGoogle Scholar
  23. Isobe N, Yoshimura Y: Deficient proliferation and apoptosis in the granulosa and theca interna cells of the bovine cystic follicle. J Reprod Dev. 2007, 53: 1119-1124. 10.1262/jrd.19041.View ArticlePubMedGoogle Scholar
  24. National Research Council: Guide for the Care and Use of Laboratory Animals. 1996, Washington, National Academy PressGoogle Scholar
  25. Montes GS, Luque EH: Effects of ovarian steroids on vaginal smears in the rat. Acta Anat. 1988, 133: 192-199. 10.1159/000146639.View ArticlePubMedGoogle Scholar
  26. Ortega HH, Salvetti NR, Padmanabhan V: Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction. 2009, 137: 865-877. 10.1530/REP-08-0491.PubMed CentralView ArticlePubMedGoogle Scholar
  27. International Committee on Veterinary Histological Nomenclature: Nomina Histologica. 1994, New York: Cornell, 2Google Scholar
  28. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992, 119: 493-501. 10.1083/jcb.119.3.493.View ArticlePubMedGoogle Scholar
  29. Huppertz B, Frank HG, Kaufmann P: The apoptosis cascade: morphological and immunohistochemical methods for its visualization. Anat Embryol. 1999, 200: 1-18. 10.1007/s004290050254.View ArticlePubMedGoogle Scholar
  30. Ranefall P, Wester K, Andersson AC, Busch C, Bengtsson E: Automatic quantification of immunohistochemically stained cell nuclei based on standard reference cells. Anal Cell Pathol. 1998, 17: 111-123.View ArticlePubMedGoogle Scholar
  31. Ortega HH, Palomar MM, Acosta JC, Salvetti NR, Dallard BE, Lorente JA, Barbeito C, Gimeno EJ: Insulin-like growth factor I in ovarian follicles and follicular fluid from cows with spontaneous and induced Cystic Ovarian Disease. Res Vet Sci. 2008, 84: 419-427. 10.1016/j.rvsc.2007.05.010.View ArticlePubMedGoogle Scholar
  32. Salvetti NR, Baravalle C, Mira GA, Gimeno EJ, Dallard BE, Rey F, Ortega HH: Heat shock protein 70 and sex steroid receptors in the follicular structures of induced ovarian cysts. Reprod Domest Anim. 2008,Google Scholar
  33. Wang H, Masironi B, Eriksson H, Sahlin L: A comparative study of estrogen receptors α and β in the rat uterus. Biol Reprod. 1999, 61: 955-964. 10.1095/biolreprod61.4.955.View ArticlePubMedGoogle Scholar
  34. Lejeune M, Jaén J, Pons L, López C, Salvadó MT, Bosch R, García M, Escrivà P, Baucells J, Cugat X, Alvaro T: Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure. J Anat. 2008, 212: 868-878. 10.1111/j.1469-7580.2008.00910.x.PubMed CentralView ArticlePubMedGoogle Scholar
  35. Isobe N, Yoshimura Y: Immunocytochemical study of cell proliferation in the cystic ovarian follicles in cows. Theriogenology. 2000, 54: 1159-1169. 10.1016/S0093-691X(00)00423-4.View ArticlePubMedGoogle Scholar
  36. Ortega HH, Stangaferro ML, Salvetti NR, Arcangelo D, Palomar MM: Estudio del balance proliferación/apoptosis en estructuras foliculares de bovinos con enfermedad quística ovárica inducida experimentalmente. Medicina. 2007, 67 (Suppl 3): 185-Google Scholar
  37. Baravalle C, Salvetti NR, Mira GA, Lorente JA, Ortega HH: Role ofACTH in the pathogenesis ofPolycystic Ovarian Syndrome in the rat:hormonal profiles andovarian morphology. Physiological Research. 2007, 56: 67-78.PubMedGoogle Scholar
  38. Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, Raveendran M, Storey A: Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. J Clin Endocr Metab. 2008, 93: 881-887. 10.1210/jc.2007-1650.PubMed CentralView ArticlePubMedGoogle Scholar
  39. Choi HS, Möstl E, Bamberg E: Progesterone, 17α-hydroxyprogesterone, androgens and oestrogens in bovine ovarian cysts. Anim Reprod Sci. 1983, 5: 175-179. 10.1016/0378-4320(83)90024-6.View ArticleGoogle Scholar
  40. Hillier SG: Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol. 2001, 179: 39-46. 10.1016/S0303-7207(01)00469-5.View ArticlePubMedGoogle Scholar
  41. Hirshfield AN: Comparison of granulosa cell proliferation in small follicles of hypophysectomized, prepubertal, and mature rats. Biol Reprod. 1985, 32: 979-987. 10.1095/biolreprod32.4.979.View ArticlePubMedGoogle Scholar
  42. Duleba AJ, Foyouzi N, Karaca M, Pehlivan T, Kwintkiewicz J, Behrman HR: Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress. Hum Reprod. 2004, 19: 1519-1524. 10.1093/humrep/deh299.View ArticlePubMedGoogle Scholar
  43. Duleba AJ, Spaczynski RZ, Olive DL, Behrman HR: Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol Reprod. 1997, 56: 891-897. 10.1095/biolreprod56.4.891.View ArticlePubMedGoogle Scholar
  44. Farookhi R: Effects of androgen on induction of gonadotropin receptors and gonadotropin-stimulated adenosine 3',5'-monophosphate production in rat ovarian granulosa cells. Endocrinology. 1980, 106: 1216-1223.View ArticlePubMedGoogle Scholar
  45. Bagnell CA, Mills TM, Costoff A, Mahesh VB: A model for the study of androgen effects on follicular atresia and ovulation. Biol Reprod. 1982, 27: 903-914. 10.1095/biolreprod27.4.903.View ArticlePubMedGoogle Scholar
  46. Kaipia A, Hsueh AJW: Regulation of ovarian follicle atresia. Annu Rev Physiol. 1997, 59: 349-363. 10.1146/annurev.physiol.59.1.349.View ArticlePubMedGoogle Scholar
  47. Anderson E, Lee GY: The polycystic ovarian (PCOD) condition: apoptosis and epithelization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model. Tissue & Cell. 1997, 29: 171-189. 10.1016/S0040-8166(97)80017-1.View ArticleGoogle Scholar
  48. Isobe N, Yoshimura Y: Localization of apoptotic cells in the cystic ovarian follicles of cows: a DNA-end labeling histochemical study. Theriogenology. 2000, 53: 897-904. 10.1016/S0093-691X(00)00238-7.View ArticlePubMedGoogle Scholar
  49. Almahbobi G, Anderiesz C, Hutchinson P, McFarlane JR, Wood C, Trounson AO: Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol (Oxf). 1996, 44 (5): 571-580. 10.1046/j.1365-2265.1996.724545.x.View ArticlePubMedGoogle Scholar
  50. Yacobi K, Wojtowicz A, Tsafriri A, Gross A: Gonadotropins enhance caspase-3 and -7 activity and apoptosis in the theca-interstitial cells of rat preovulatory follicles in culture. Endocrinology. 2004, 145: 1943-1951. 10.1210/en.2003-1395.View ArticlePubMedGoogle Scholar
  51. Robles R, Tao XJ, Trbovich AM, Maravel DV, Nahum R, Perez GI, Tilly KI, Tilly JL: Localization, regulation and possible consequences of apoptotic protease-activating factor-1 (Apaf-1) expression in granulosa cells of the mouse ovary. Endocrinology. 1999, 140: 2641-2644. 10.1210/en.140.6.2641.View ArticlePubMedGoogle Scholar
  52. Yacobi K, Tsafriri A, Gross A: Luteinizing hormone-induced caspase activation in rat preovulatory follicles is coupled to mitochondrial steroidogenesis. Endocrinology. 2007, 148: 1717-1726. 10.1210/en.2006-1533.View ArticlePubMedGoogle Scholar
  53. Johnson AL, Bridgham JT, Witty JP, Tilly JL: Susceptibility of avian ovarian granulosa cells to apoptosis is dependent upon stage of follicle development and is related to endogenous levels of bcl-xlong gene expression. Endocrinology. 1996, 137: 2059-2066. 10.1210/en.137.5.2059.PubMedGoogle Scholar
  54. Johnson AL: Intracellular mechanisms regulating cell survival in ovarian follicles. Anim Reprod Sci. 2003, 78: 185-201. 10.1016/S0378-4320(03)00090-3.View ArticlePubMedGoogle Scholar
  55. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 1995, 270: 96-99. 10.1126/science.270.5233.96.View ArticlePubMedGoogle Scholar
  56. Boone DL, Tsang BK: Non-isotopic technique for the identification of endonucleases involved in apoptosis. Biotechniques. 1997, 22: 648-649.PubMedGoogle Scholar
  57. Boone DL, Tsang BK: Caspase-3 in the rat ovary: localization and possible role in follicular atresia and luteal regression. Biol Reprod. 1998, 58: 1533-1539. 10.1095/biolreprod58.6.1533.View ArticlePubMedGoogle Scholar
  58. Calder MD, Salfen BE, Bao B, Youngquist RS, Garverick HA: Administration of progesterone to cows with ovarian follicular cysts results in a reduction in mean LH and LH pulse frequency and initiates ovulatory follicular growth. J Anim Sci. 1999, 77 (11): 3037-3042.PubMedGoogle Scholar
  59. Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H: Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007, 92: 240-245. 10.1210/jc.2006-1582.View ArticlePubMedGoogle Scholar

Copyright

© Salvetti et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement